REGULATION OF ROS-DEPENDENT SIGNALING BY A NEW METABOLIC DRUG MP-33 IN CASE OF ISCHEMIC HEART DISEASE ArticleKalinina E.V., Komissarova I.A., Zaslavskaya R.M.Free Radical Biology & Medicine. Vol. 33. 2002. S226 p..
INCREASING OF ANTIOXIDANT STATUS OF AGING PATIENTS WITH OXIDATIVE-RELATED DISEASES BY METABOLIC DRUG MP-33 ArticleKalinina E.V., Zaslavskaya R.M., Komissarova I.A.Biogerontology. Vol. 3. 2002. 58 p..